The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[(acetyloxy)methyl]-3-hydroxypropyl 2-{4-[(1R)-1-[(4-chloro-1,6-dimethyl-1H-indol-2-yl)formamido]ethyl]benzenesulfonyl}acetate ID: ALA4547319
PubChem CID: 142427898
Max Phase: Preclinical
Molecular Formula: C27H31ClN2O8S
Molecular Weight: 579.07
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)OCC(CO)COC(=O)CS(=O)(=O)c1ccc([C@@H](C)NC(=O)c2cc3c(Cl)cc(C)cc3n2C)cc1
Standard InChI: InChI=1S/C27H31ClN2O8S/c1-16-9-23(28)22-11-25(30(4)24(22)10-16)27(34)29-17(2)20-5-7-21(8-6-20)39(35,36)15-26(33)38-14-19(12-31)13-37-18(3)32/h5-11,17,19,31H,12-15H2,1-4H3,(H,29,34)/t17-,19?/m1/s1
Standard InChI Key: VWLNFKJCAYYRJK-DUSLRRAJSA-N
Molfile:
RDKit 2D
39 41 0 0 0 0 0 0 0 0999 V2000
17.9658 -4.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6109 -6.3497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1445 -5.7740 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1486 -4.9568 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.4389 -5.3618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7860 -3.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4941 -3.6883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2009 -2.4562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2057 -3.2748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9857 -3.5233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4631 -2.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9780 -2.1987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2803 -2.8533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6930 -3.5586 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6847 -2.1432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5018 -2.1384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9063 -1.4283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9146 -2.8437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5073 -3.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9193 -4.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7374 -4.2538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1416 -3.5387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7272 -2.8368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2428 -4.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3815 -5.6521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1987 -5.6438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9801 -6.3639 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7872 -2.4598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4912 -2.0521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4883 -1.2349 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.0780 -3.6874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4281 -6.3456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8402 -7.0513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4351 -7.7610 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8332 -5.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6503 -5.6319 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.0554 -4.9221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8726 -4.9181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6433 -4.2165 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4 3 2 0
5 4 2 0
28 6 2 0
6 7 1 0
7 9 2 0
8 29 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
11 13 1 0
13 14 2 0
13 15 1 0
16 15 1 6
16 17 1 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 4 1 0
4 1 1 0
10 24 1 0
1 25 1 0
25 26 1 0
25 27 2 0
28 29 1 0
26 2 1 0
29 30 1 0
6 31 1 0
2 32 1 0
32 33 1 0
33 34 1 0
32 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
37 39 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 579.07Molecular Weight (Monoisotopic): 578.1490AlogP: 3.12#Rotatable Bonds: 11Polar Surface Area: 141.00Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.44CX Basic pKa: ┄CX LogP: 2.58CX LogD: 2.58Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.33Np Likeness Score: -0.82
References 1. (2018) Tosylacetate based compounds and derivatives thereof as phgdh inhibitors,